A radical cystectomy is a major surgery that removes the entire bladder along with nearby tissues and lymph nodes. It is the standard surgical treatment for muscle-invasive bladder cancer (stages II and III) and is sometimes used for high-grade early-stage cancers that haven’t responded to less aggressive treatments. Because the bladder is gone after surgery, a new way to store or drain urine must be created at the same time.
When Radical Cystectomy Is Recommended
The primary reason for this surgery is bladder cancer that has grown into the muscle wall of the bladder. For stage II and stage III bladder cancer, the two main treatment paths are radical cystectomy or a combination of radiation therapy and chemotherapy. In stage IVA disease, where cancer has spread locally but not to distant organs, surgeons may recommend chemotherapy first followed by radical cystectomy.
Not all bladder cancers require removing the entire organ. Early-stage tumors that sit on the bladder’s inner lining are typically treated with less invasive procedures. But when a patient has multiple tumors, a type of high-grade early cancer called carcinoma in situ that keeps coming back, or cancer that has invaded the muscle layer, radical cystectomy becomes a primary option.
What the Surgery Removes
The bladder itself is only part of what’s taken out. Surrounding tissues and nearby lymph nodes are removed to reduce the chance that cancer cells have spread beyond the bladder wall. Beyond that, the specific organs removed differ between men and women.
In men, the surgery typically includes removal of the prostate and seminal vesicles along with the bladder. In women, the standard procedure involves removing the bladder, urethra, ovaries, fallopian tubes, uterus, and the front wall of the vagina, all as a single connected block of tissue. Lymph node dissection is performed in both cases. In select female patients, organ-sparing approaches that preserve some reproductive structures are being explored, though the standard approach remains more extensive.
Open Surgery vs. Robotic Surgery
Radical cystectomy can be performed through a large abdominal incision (open surgery) or with robotic-assisted instruments through smaller incisions. A meta-analysis of nine randomized controlled trials found that open surgery is faster to perform, taking roughly an hour less in the operating room. Robotic surgery, however, results in significantly less blood loss, around 200 mL less on average.
When it comes to the outcomes that matter most to patients, the two approaches are essentially equivalent. Hospital stays are similar in length, and cancer recurrence rates show no meaningful difference between the techniques. The choice often depends on the surgeon’s expertise and the specifics of a patient’s anatomy and cancer.
How Urine Is Rerouted
Once the bladder is removed, urine still needs somewhere to go. Surgeons create a urinary diversion using a segment of the patient’s own intestine. There are three main approaches, and the choice depends on cancer location, body type, kidney function, and patient preference.
- Ileal conduit: The most common and simplest option. The surgeon takes a short piece of small intestine (about 15 cm), connects the ureters to one end, and brings the other end through the abdominal wall to create a small opening called a stoma. Urine drains continuously into an external pouch worn on the skin. This is considered an “incontinent” diversion because you don’t control when urine flows.
- Neobladder: A longer segment of small intestine (roughly 55 cm) is reshaped and folded into a pouch that mimics the original bladder. This internal reservoir connects to the urethra, allowing you to urinate in a relatively normal way. It takes time to retrain your body, and some people need to use a catheter occasionally to fully empty it.
- Continent cutaneous diversion: A surgically created internal pouch with a valve-like channel to the skin. Instead of an external bag, you insert a thin catheter through the stoma several times a day to drain the reservoir.
Preparing for Surgery
Radical cystectomy is one of the more physically demanding operations in cancer surgery, so preparation matters. Many cancer centers now use “prehabilitation” programs in the weeks before surgery. These typically include a physical therapist-supervised exercise program with three sessions per week, nutritional guidance from a registered dietitian, psychological counseling, and intensive smoking cessation support for current smokers. The goal is to go into surgery in the strongest possible condition, which directly affects how smoothly recovery goes.
What Recovery Looks Like
Modern recovery protocols, known as enhanced recovery after surgery (ERAS), aim to get patients eating and moving as quickly as possible. There is no routine use of a nasogastric tube after surgery, and patients are encouraged to start eating and walking early in the postoperative period. Urinary catheters and surgical drains are removed as soon as safely possible, sometimes within the first day or two if there are no signs of urine leakage.
Hospital stays typically run about a week, though this varies. The first few weeks at home involve gradually increasing activity, adjusting to the new urinary system, and managing fatigue. Full recovery to normal energy levels and activity often takes two to three months. During this period, patients learn to care for a stoma or adapt to how a neobladder functions, which involves a significant learning curve either way.
Complications to Expect
This is a complex surgery, and complication rates reflect that. Urinary tract infections occur in roughly 9% of patients within 30 days. Wound infections affect about 11%. The gastrointestinal tract, which has been surgically rearranged to create the urinary diversion, can be slow to wake up after surgery, causing temporary bloating and nausea.
Because a portion of the small intestine is now handling urine instead of absorbing nutrients, long-term metabolic changes can occur. Vitamin B12 deficiency develops in about 17% of patients with bowel-based diversions. European urology guidelines recommend yearly B12 blood tests for anyone with this type of diversion. Follow-up visits during the first year are commonly scheduled every three months, with CT scans of the abdomen and chest performed regularly for at least five years to watch for cancer recurrence.
Impact on Sexual Health
Sexual function changes significantly after radical cystectomy, and this is one of the most underaddressed aspects of the surgery. In men, the removal of the prostate and seminal vesicles can damage the nerve bundles that control erections. Erectile dysfunction occurs in roughly 30% to 60% of male patients. Even when erections are possible, maintaining them can be difficult due to changes in blood supply to the penis. Nerve-sparing techniques can reduce this risk in carefully selected patients, but the results are not guaranteed.
For women, the removal of part of the vaginal wall can shorten the vagina, leading to discomfort or pain during intercourse. Vaginal dryness is a common issue, sometimes persisting even with lubricants. The risk of pelvic organ prolapse also increases. Women frequently report that these physical changes, combined with emotional adjustment, significantly affect intimacy and desire.
Survival After Surgery
Long-term survival depends heavily on how far the cancer has advanced at the time of surgery. For cancer confined to the muscle wall of the bladder without lymph node involvement, five-year survival rates range from about 63% to 68%. When cancer has grown through the bladder wall but not reached lymph nodes, five-year survival is roughly 50% to 62%. For patients whose cancer has spread to nearby lymph nodes, the five-year survival rate drops to around 22% to 35%.
Overall, the five-year relapse-free survival rate following radical cystectomy falls between 60% and 70% across all stages. These numbers improve when cancer is caught before it spreads to lymph nodes, which is one reason prompt treatment of muscle-invasive disease matters. Chemotherapy given before surgery can improve outcomes for patients with more advanced tumors, and is a standard part of treatment planning for many patients.